These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1193 related articles for article (PubMed ID: 24839938)

  • 1. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.
    Perez-Lloret S; Negre-Pages L; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Schelosky L; Tison F; Rascol O
    JAMA Neurol; 2014 Jul; 71(7):884-90. PubMed ID: 24839938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study.
    Amboni M; Stocchi F; Abbruzzese G; Morgante L; Onofrj M; Ruggieri S; Tinazzi M; Zappia M; Attar M; Colombo D; Simoni L; Ori A; Barone P; Antonini A;
    Parkinsonism Relat Disord; 2015 Jun; 21(6):644-9. PubMed ID: 25899545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
    Giladi N; Tal J; Azulay T; Rascol O; Brooks DJ; Melamed E; Oertel W; Poewe WH; Stocchi F; Tolosa E
    Mov Disord; 2009 Apr; 24(5):655-61. PubMed ID: 19127595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gait impairment with and without freezing of gait in Parkinson's disease.
    Josiah AF; Gruber-Baldini AL; Anderson KE; Fishman PS; Weiner WJ; Reich SG; Shulman LM
    Parkinsonism Relat Disord; 2012 Mar; 18(3):239-42. PubMed ID: 22079524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-year population-based study of freezing of gait in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
    Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease.
    Zibetti M; Angrisano S; Dematteis F; Artusi CA; Romagnolo A; Merola A; Lopiano L
    J Neurol Sci; 2018 Feb; 385():105-108. PubMed ID: 29406886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid levels and freezing of gait in Parkinson's disease.
    Ou R; Cao B; Wei Q; Hou Y; Xu Y; Song W; Zhao B; Shang H
    Neurol Sci; 2017 Jun; 38(6):955-960. PubMed ID: 28251464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freezing of gait in patients with advanced Parkinson's disease.
    Giladi N; Treves TA; Simon ES; Shabtai H; Orlov Y; Kandinov B; Paleacu D; Korczyn AD
    J Neural Transm (Vienna); 2001; 108(1):53-61. PubMed ID: 11261746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.
    Reichmann H; Boas J; Macmahon D; Myllyla V; Hakala A; Reinikainen K;
    Acta Neurol Scand; 2005 Jan; 111(1):21-8. PubMed ID: 15595934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
    Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
    Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falls in ambulatory non-demented patients with Parkinson's disease.
    Rascol O; Perez-Lloret S; Damier P; Delval A; Derkinderen P; Destée A; Meissner WG; Tison F; Negre-Pages L
    J Neural Transm (Vienna); 2015 Oct; 122(10):1447-55. PubMed ID: 25845678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of fatigue in Parkinson disease and its clinical correlates.
    Stocchi F; Abbruzzese G; Ceravolo R; Cortelli P; D'Amelio M; De Pandis MF; Fabbrini G; Pacchetti C; Pezzoli G; Tessitore A; Canesi M; Iannacone C; Zappia M;
    Neurology; 2014 Jul; 83(3):215-20. PubMed ID: 24928125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining freezing of gait in Parkinson's disease: motor and cognitive determinants.
    Vercruysse S; Devos H; Munks L; Spildooren J; Vandenbossche J; Vandenberghe W; Nieuwboer A; Heremans E
    Mov Disord; 2012 Nov; 27(13):1644-51. PubMed ID: 23115014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associated factors and abnormal dorsal raphe nucleus connectivity patterns of freezing of gait in Parkinson's disease.
    Lv L; Zhang H; Tan X; Long Z; Qin L; Bai R; Xiao Q; Wu Z; Hu S; Tan C; Liao H; Yan W; Tang B; Ren F; Wang C
    J Neurol; 2022 Dec; 269(12):6452-6466. PubMed ID: 35933494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of medication and the role of postural instability in different components of freezing of gait (FOG).
    Nantel J; Bronte-Stewart H
    Parkinsonism Relat Disord; 2014 Apr; 20(4):447-51. PubMed ID: 24530016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.